Camp4 Therapeutics (CAMP) Research & Development (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Research & Development of $10.82 million for Q2 2026, up 4.6% from $10.34 million a year earlier and up 6.5% from the prior quarter.
Powered by 
Analysis
Camp4 Therapeutics (CAMP) Research & Development (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Camp4 Therapeutics' Research & Development came in at $38.69 million, down 3.7% year-over-year; for FY2025, it came in at $38.2 million, down 1.6% from FY2024.
- By year, Research & Development came in at $38.82 million in FY2024 (-4.4%) and $40.62 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Research & Development in data going back to Q3 2023.
- Year over year, Research & Development gained in four of the last eight quarters, with an average decline of 1.0%.
- The high point for year-over-year Research & Development in five years was Q2 2025 (growth of 10.2%); the low point was Q4 2025 (a decline of 16.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $10.16 million (Q1 2026), $8.36 million (Q4 2025) and $9.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Camp4 Therapeutics | 341.83 Mn | -77.81 Mn | - | 11.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.43 Mn |
| Jun 30, 2026 | 10.82 Mn |
| Mar 31, 2026 | 10.16 Mn |
| Dec 31, 2025 | 7.86 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Jun 30, 2025 | 10.34 Mn |
| Mar 31, 2025 | 10.15 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Sep 30, 2024 | 9.70 Mn |
| Jun 30, 2024 | 9.39 Mn |
| Mar 31, 2024 | 9.74 Mn |
| Dec 31, 2023 | 10.66 Mn |
| Sep 30, 2023 | 9.82 Mn |
API Access
Camp4 Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CAMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CAMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CAMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();